Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
Generate:Biomedicines is hoping to raise up to $425 million via a Nasdaq IPO, with the proceeds needed to bankroll its lead antibody through respiratory disease trials. The Flagship Pioneering-founded ...
Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...
Random numbers are very important to us in this computer age, being used for all sorts of security and cryptographic tasks. [Theory to Thing] recently built a device to generate random numbers using ...
Gerd Faltings, a number theorist at the Max Planck Institute for Mathematics in Bonn, Germany, has won the 2026 Abel Prize, one of the most prestigious awards in mathematics, the Norwegian Academy of ...
Mary Hall is a editor for Investopedia's Advisor Insights, in addition to being the editor of several books and doctoral papers. Mary received her bachelor's in English from Kent State University with ...
Melissa Horton is a financial literacy professional. She has 10+ years of experience in the financial services and planning industry. Robert Kelly is managing director of XTS Energy LLC, and has more ...
Forbes contributors publish independent expert analyses and insights. Non-fungible tokens have transformed the art world, offering artists innovative ways to create, sell and profit from their digital ...
Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results